Todos Med Ltd (TOMDF)

[misiu143]

There is nothing as a game changer in this drug...leronlimab showed results in critical , patients on the ventilators and ECMO , 82% mortality benefit above all the toxic , drugs with minimal efficacy approved by FDA ...

This drug showed nothing much really ...if you compare to leronlimab and even to the small studies with Tollovir ...

I feel about this drug and this study as an author of this article below ..They saying 45% on SOC and placebo died ..well ....45% ????? please show me any other study with this numbers ....

As always all imo...

https://insiderfinancial.com/verus-nasdaq-veru-repurposed-covid-19-drug-facing-uphill-battle-for-eua/183126/